VanEck Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $67.9M | Sell |
193,115
-624,719
| -76% | -$223M | 0.05% | 229 |
|
|
2025
Q4 | $268M | Sell |
817,834
-540,258
| -40% | -$171M | 0.22% | 93 |
|
|
2025
Q3 | $383M | Buy |
1,358,092
+567,400
| +72% | +$165M | 0.36% | 63 |
|
|
2025
Q2 | $221M | Sell |
790,692
-162,164
| -17% | -$45.9M | 0.25% | 91 |
|
|
2025
Q1 | $297M | Sell |
952,856
-85,737
| -8% | -$25.3M | 0.38% | 69 |
|
|
2024
Q4 | $271M | Buy |
1,038,593
+753,147
| +264% | +$223M | 0.35% | 68 |
|
|
2024
Q3 | $89.9M | Buy |
285,446
+18,573
| +7% | +$6.08M | 0.11% | 131 |
|
|
2024
Q2 | $83.4M | Sell |
266,873
-911
| -0.3% | -$268K | 0.12% | 132 |
|
|
2024
Q1 | $76.1M | Sell |
267,784
-56,033
| -17% | -$16.4M | 0.12% | 133 |
|
|
2023
Q4 | $93.3M | Sell |
323,817
-599,315
| -65% | -$163M | 0.17% | 119 |
|
|
2023
Q3 | $248M | Buy |
923,132
+66,399
| +8% | +$16.6M | 0.54% | 63 |
|
|
2023
Q2 | $190M | Buy |
856,733
+565,032
| +194% | +$131M | 0.42% | 70 |
|
|
2023
Q1 | $70.5M | Buy |
291,701
+21,269
| +8% | +$5.22M | 0.16% | 126 |
|
|
2022
Q4 | $71M | Sell |
270,432
-34,705
| -11% | -$9.3M | 0.18% | 126 |
|
|
2022
Q3 | $68.8M | Buy |
305,137
+26,346
| +9% | +$6.39M | 0.2% | 122 |
|
|
2022
Q2 | $67.8M | Sell |
278,791
-10,433
| -4% | -$2.56M | 0.18% | 130 |
|
|
2022
Q1 | $69.9M | Sell |
289,224
-26,971
| -9% | -$6.2M | 0.14% | 146 |
|
|
2021
Q4 | $71.1M | Buy |
316,195
+60,606
| +24% | +$12.8M | 0.16% | 135 |
|
|
2021
Q3 | $54.4M | Buy |
255,589
+25,117
| +11% | +$5.78M | 0.14% | 158 |
|
|
2021
Q2 | $56.2M | Sell |
230,472
-30,120
| -12% | -$7.41M | 0.13% | 159 |
|
|
2021
Q1 | $64.8M | Sell |
260,592
-58,314
| -18% | -$13.9M | 0.18% | 135 |
|
|
2020
Q4 | $73.3M | Sell |
318,906
-12,705
| -4% | -$2.93M | 0.21% | 108 |
|
|
2020
Q3 | $84.3M | Sell |
331,611
-31,064
| -9% | -$7.7M | 0.27% | 83 |
|
|
2020
Q2 | $85.5M | Buy |
362,675
+109,870
| +43% | +$25.1M | 0.3% | 71 |
|
|
2020
Q1 | $51.3M | Sell |
252,805
-193,156
| -43% | -$42.2M | 0.26% | 84 |
|
|
2019
Q4 | $108M | Sell |
445,961
-105,856
| -19% | -$23.3M | 0.42% | 43 |
|
|
2019
Q3 | $107M | Buy |
551,817
+161,824
| +41% | +$31.1M | 0.5% | 33 |
|
|
2019
Q2 | $71.9M | Buy |
389,993
+177,726
| +84% | +$31.8M | 0.35% | 53 |
|
|
2019
Q1 | $40.3M | Buy |
212,267
+12,212
| +6% | +$2.33M | 0.2% | 111 |
|
|
2018
Q4 | $38.9M | Sell |
200,055
-115,096
| -37% | -$22.5M | 0.2% | 104 |
|
|
2018
Q3 | $65.3M | Sell |
315,151
-122,344
| -28% | -$24.1M | 0.32% | 73 |
|
|
2018
Q2 | $80.8M | Sell |
437,495
-40,271
| -8% | -$7.12M | 0.38% | 60 |
|
|
2018
Q1 | $81.5M | Sell |
477,766
-98,775
| -17% | -$18.1M | 0.4% | 59 |
|
|
2017
Q4 | $100M | Buy |
576,541
+6,708
| +1% | +$1.19M | 0.49% | 53 |
|
|
2017
Q3 | $106M | Sell |
569,833
-68,303
| -11% | -$12.1M | 0.54% | 47 |
|
|
2017
Q2 | $110M | Sell |
638,136
-44,915
| -7% | -$7.31M | 0.6% | 39 |
|
|
2017
Q1 | $112M | Buy |
683,051
+56,828
| +9% | +$9.44M | 0.49% | 53 |
|
|
2016
Q4 | $91.6M | Buy |
626,223
+53,879
| +9% | +$8.11M | 0.46% | 60 |
|
|
2016
Q3 | $95.5M | Sell |
572,344
-18,568
| -3% | -$3.14M | 0.44% | 57 |
|
|
2016
Q2 | $89.9M | Sell |
590,912
-53,608
| -8% | -$8.33M | 0.46% | 52 |
|
|
2016
Q1 | $96.6M | Buy |
644,520
+165,741
| +35% | +$24.6M | 0.65% | 43 |
|
|
2015
Q4 | $77.7M | Sell |
478,779
-76,462
| -14% | -$12M | 0.62% | 43 |
|
|
2015
Q3 | $76.8M | Sell |
555,241
-295,510
| -35% | -$46.6M | 0.59% | 46 |
|
|
2015
Q2 | $131M | Sell |
850,751
-24,513
| -3% | -$3.93M | 0.77% | 35 |
|
|
2015
Q1 | $140M | Buy |
875,264
+384,979
| +79% | +$60.6M | 0.81% | 34 |
|
|
2014
Q4 | $78.1M | Buy |
490,285
+49,986
| +11% | +$7.79M | 0.49% | 57 |
|
|
2014
Q3 | $61.8M | Sell |
440,299
-358,640
| -45% | -$46.8M | 0.33% | 73 |
|
|
2014
Q2 | $94.6M | Buy |
798,939
+262,237
| +49% | +$30.4M | 0.44% | 58 |
|
|
2014
Q1 | $66.2M | Buy |
536,702
+72,275
| +16% | +$8.77M | 0.33% | 70 |
|
|
2013
Q4 | $53M | Buy |
464,427
+30,129
| +7% | +$3.43M | 0.27% | 82 |
|
|
2013
Q3 | $48.6M | Buy |
434,298
+2,770
| +0.6% | +$300K | 0.25% | 80 |
|
|
2013
Q2 | $42.6M | Buy |
+431,528
| New | +$44.8M | 0.23% | 83 |
|
Other funds holding AMGN
VCM
VPM
VanEck Associates's AMGN Position: Q1 2026 in Review
VanEck Associates reduced its Amgen (AMGN) stake by 76% in Q1 2026, selling an estimated $223M and leaving 193,115 shares worth $67.9M. The position accounts for 0.05% of the portfolio, ranked #229.
VanEck Associates first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $383M in Q3 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- VanEck Associates held 193,115 shares of Amgen worth $67.9M as of Q1 2026.
- VanEck Associates sold 624,719 Amgen shares in Q1 2026, an estimated $223M.
- Amgen made up 0.05% of VanEck Associates's portfolio in Q1 2026, its #229 holding.
- VanEck Associates first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- VanEck Associates's Amgen position peaked at $383M in Q3 2025.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.